Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia

INTRODUCTION: Community acquired pneumonia (CAP) may present as life-threatening infection with uncertain progression and outcome of treatment. Primary aim of the trial was determination of the cut-off value of serum interleukin-6 (IL-6) and procalcitonin (PCT) above which, 30-day mortality in hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrijevic, Ilija, Matijasevic, Jovan, Andrijevic, Ljiljana, Kovacevic, Tomi, Zaric, Bojan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073574/
https://www.ncbi.nlm.nih.gov/pubmed/24987476
http://dx.doi.org/10.4103/1817-1737.134072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073574/
https://www.ncbi.nlm.nih.gov/pubmed/24987476
http://dx.doi.org/10.4103/1817-1737.134072

Ejemplares similares